RheumPAC donors attended a virtual legislative update and Q&A with former pediatrician Rep. Kim Schrier, MD (D-Wash.), to gain an insider’s view of current healthcare legislation.
Articles by From the College
Changes in ICD-10 for Sjögren’s Syndrome
A code change in the ICD-10 classification for Sjögren’s syndrome was approved by the ICD-10 Coordination and Maintenance Committee in July 2019 and becomes effective October 2020.
Out-of-Pocket Costs for Patients with Rheumatic Diseases Skyrocket
An estimated one in four American adults live with a rheumatic disease, and according to a new national patient survey by the ACR, the healthcare and lifestyle challenges have become worse for these patients during the COVID-19 pandemic. Key survey findings include: Patients currently seeing a rheumatologist declined 52% between 2019 and 2020; 68% of…
Continuing Medical Education Credit, Maintenance of Certification Points Now Available Through ACR’s RISE Registry
Rheumatology Informatics System for Effectiveness registry users can complete an online performance improvement activity to earn up to 20 continuing medical education credits and 20 maintenance of certification points.
CMS Releases 2021 Proposed Rule for the Quality Payment Program
The ACR has highlighted critical changes for the 2021 performance year outlined in the proposed rule released Aug. 3 by the Centers for Medicare & Medicaid Services.
ACR Leaders Discuss Hydroxychloroquine Issues with FDA Commissioner
The conversation with Stephen Hahn, MD, addressed challenges associated with hydroxychloroquine access during the COVID-19 public health emergency and handling patient concerns about potential cardiac side effects.
The ACR Expresses Strong Support for Dr. Anthony Fauci
The ACR, on behalf of its more than 7,700 members of the professional rheumatology community, wishes to express strong support for Anthony S. Fauci, MD, director of the National Institute of Allergy and Infectious Diseases (NIAID), and his continued and close involvement in the work to address the nation’s response to the COVID-19 pandemic. During…
ACR Updates COVID-19 Clinical Guidance for Adult Patients
Note: This article was updated July 21 to add recommendations on restarting biologics following COVID-19. On April 29, the ACR released Guidance for the Management of Adult Patients with Rheumatic Disease During the COVID‐19 Pandemic and later updated the guidance for publication in Arthritis & Rheumatology. The recommendations address various treatment options and provide general…
Joint Letter to CMS Advocates Against Adding Stelara to Self-Administered Drug List
The ACR, CSRO and Arthritis Foundation asked the Centers for Medicare & Medicaid Services to review the decision to add Stelara to the Self-Administered Drugs list, which would limit access for patients who can’t self-administer.
ACR Releases COVID-19 Clinical Guidance for Pediatric Patients
The ACR has developed two new clinical guidance documents for pediatric patients in the context of the COVID-19 pandemic.
- « Previous Page
- 1
- …
- 27
- 28
- 29
- 30
- 31
- …
- 98
- Next Page »